Anant Ramaswamy (@anantramaswamy) 's Twitter Profile
Anant Ramaswamy

@anantramaswamy

I exist

ID: 1268057119359553536

calendar_today03-06-2020 05:49:26

170 Tweet

698 Followers

32 Following

Manish S Bhandare (@manishbhandare4) 's Twitter Profile Photo

CA 19-9 is of great value in Ampullary cancers too Should be a routine surveillance test Our work to featureĀ inĀ Annals of Surgery for the 1st time,Ā hoping this to be a good beginning Gurudutt P. VartyĀ special congratulations to you šŸ¤šŸ‘ journals.lww.com/annalsofsurger… Shailesh V. Shrikhande

CA 19-9 is of great value in Ampullary cancers too
Should be a routine surveillance test

Our work to featureĀ inĀ <a href="/AnnalsofSurgery/">Annals of Surgery</a> for the 1st time,Ā hoping this to be a good beginning

<a href="/DrGuruduttVarty/">Gurudutt P. Varty</a>Ā special congratulations to you šŸ¤šŸ‘

journals.lww.com/annalsofsurger…

<a href="/Shrikhande_SV/">Shailesh V. Shrikhande</a>
Dr (Prof). Vijay Patil (@drvijaypatil11) 's Twitter Profile Photo

Phase III randomized trial of neoadjuvant paclitaxel+platinum to 5-fluorouracil+platinum in esophageal/GEJ squamous cell carcinoma academic.oup.com/jnci/article-a…. Paclitaxel Platinum is as good as platinum 5 FU. Vanita Noronha, MBBS MD DM Nandini Menon bhawna sirohi Dr Amol Akhade Amol Patel

Dr Amol Akhade (@suyogcancer) 's Twitter Profile Photo

My wishlist from #SantaClaus and from 2025 in oncology , as oncologist who practices in developing country like India šŸ‡®šŸ‡³ , at community level and has a keen interest in analyzing data and is active on Social Media voicing opinion ( un filtered šŸ˜€ and un biased ) 1- Let

Dr Amol Akhade (@suyogcancer) 's Twitter Profile Photo

Top 10 GI Trials – ASCO 2025 The biggest GI breakthroughs you must track this year! 🧬 ATOMIC – Atezolizumab + FOLFOX in stage III MSI-H colon šŸ›”ļø MATTERHORN – Durvalumab + FLOT in gastric/GEJ 🧪 DYNAMIC-III – ctDNA-guided chemo in colon šŸ’‰ DESTINY-Gastric04 – T-DXd vs RAM+PTX

Top 10 GI Trials – ASCO 2025
The biggest GI breakthroughs you must track this year!

🧬 ATOMIC – Atezolizumab + FOLFOX in stage III MSI-H colon

šŸ›”ļø MATTERHORN – Durvalumab + FLOT in gastric/GEJ

🧪 DYNAMIC-III – ctDNA-guided chemo in colon

šŸ’‰ DESTINY-Gastric04 – T-DXd vs RAM+PTX